(Q46490757)

22 December 2017

title

Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats (English)

1 reference

22 December 2017

1 reference

Kelli M Jones

1

1 reference

22 December 2017

Ivar M McDonald

2

1 reference

22 December 2017

Clotilde Bourin

3

1 reference

22 December 2017

Richard E Olson

4

1 reference

22 December 2017

Linda J Bristow

5

1 reference

22 December 2017

Amy Easton

6

1 reference

22 December 2017

publication date

21 September 2013

1 reference

22 December 2017

published in

Psychopharmacology

1 reference

22 December 2017

volume

231

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

673-683

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-013-3275-6

exact match

0 references

cites work

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Preclinical behavioral models for predicting antipsychotic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Clozapine, SCH 23390 and alpha-flupenthixol but not haloperidol attenuate acute phencyclidine-induced disruption of conditional discrimination performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

The prefrontal cortex--an update: time is of the essence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetize

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Meta-analysis of the acute effects of nicotine and smoking on human performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Anomalous Lateral Sulcus Asymmetry and Cognitive Function in First-episode Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Serotonin and dopamine: unifying affective, activational, and decision functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

An analysis of rat prefrontal cortex in mediating executive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Nicotine use in schizophrenia: the self medication hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Neuroplasticity of neocortical circuits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Cortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

CATIE and CUtLASS: can we handle the truth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

An integrative theory of prefrontal cortex function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Neurocognitive predictors of work outcome in recent-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Cognitive effects of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

The frontal lobes and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3275-6

Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test

21 January 2018

1 reference

12 December 2020

Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus.

1 reference

12 December 2020

Involvement of the prelimbic-infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning.

1 reference

12 December 2020

Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells.

1 reference

12 December 2020

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

1 reference

12 December 2020

Medial frontal cortex mediates perceptual attentional set shifting in the rat.

1 reference

12 December 2020

Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice

1 reference

12 December 2020

Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin.

1 reference

12 December 2020

Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.

1 reference

12 December 2020

10.1007/S00213-013-3275-6

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

24057763

1 reference

22 December 2017